Multivariant Covid-19 vaccine booster shows promise, early trial data suggests

Multivariant Covid-19 vaccine booster shows promise, early trial data suggests (Danny Lawson/PA)

A Covid vaccine booster aimed at tackling multiple variants shows promise in inducing a comprehensive immune response, early data in Britain suggests.

The first results of a phase one trial, launched in Manchester in September 2021, reveal the jab has strong levels of neutralising antibodies.